Final 5‐Year Report of the Randomized BIO‐RESORT Trial Comparing 3 Contemporary Drug‐Eluting Stents in All‐Comers

Final 5‐Year Report of the Randomized BIO‐RESORT Trial Comparing 3 Contemporary Drug‐Eluting Stents in All‐Comers

Background In a previous trial, higher 5‐year mortality was observed following treatment with biodegradable polymer Orsiro sirolimus‐eluting stents (SES). We assessed 5‐year safety and efficacy of all‐comers as well as patients with diabetes treated with SES or Synergy everolimus‐eluting stents (EES...

Full description

Bibliographic Details
Main Authors: Eline H. Ploumen, Tineke H. Pinxterhuis, Rosaly A. Buiten, Paolo Zocca, Peter W. Danse, Carl E. Schotborgh, Martijn Scholte, R. Melvyn Tjon Joe Gin, Samer Somi, K. Gert van Houwelingen, Martin G. Stoel, H. A. F. de Man, Marc Hartmann, Gerard C. M. Linssen, Liefke C. van der Heijden, Marlies M. Kok, Carine J. M. Doggen, Clemens von Birgelen
Format: Article
Language:English
Published: Wiley 2022-11-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
biodegradable polymer
drug‐eluting stent
durable polymer
percutaneous coronary intervention
randomized clinical trial
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.122.026041

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.122.026041

Similar Items